Showing 1 - 10 of 95
Rationale Increasing attention is being given to the evaluation of public health interventions. Methods for the economic evaluation of clinical interventions are well established. In contrast, the economic evaluation of public health interventions raises additional methodological challenges. The...
Persistent link: https://www.econbiz.de/10008483573
The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of trastuzumab, Roche Pharmaceuticals, to submit evidence for the clinical and cost effectiveness of this drug for the treatment of advanced gastric cancer (aGC), as part of the Institute’s single...
Persistent link: https://www.econbiz.de/10010848963
Persistent link: https://www.econbiz.de/10009404157
This paper presents the results of a detailed survey designed to explore the factors associated with purchase of private health insurance in England. The survey, a nationally representative survey of the population of England aged 25 to 70, was carried out in the first 4 months of 1987. The...
Persistent link: https://www.econbiz.de/10005548007
This paper compares the use of parametric and non-parametric approaches to adjust for heterogeneity in self-reported data. Despite the growing popularity of the HOPIT model to account for reporting heterogeneity when dealing with self-reported categorical data, recent evidence has questioned the...
Persistent link: https://www.econbiz.de/10010602596
This paper presents a method by which the opportunity cost of sales of local authority housing might be assessed, taking account of the financial effects of sales on taxpayers and ratepayers and in particular the effects on waiting list applicants. A method is suggested by which the pattern of...
Persistent link: https://www.econbiz.de/10010885374
Persistent link: https://www.econbiz.de/10010885917
Persistent link: https://www.econbiz.de/10005306723
Persistent link: https://www.econbiz.de/10005328556
Persistent link: https://www.econbiz.de/10005123140